Overdiagnosis among women attending a population-based mammography screening program
- PMID: 23355313
- PMCID: PMC3708102
- DOI: 10.1002/ijc.28052
Overdiagnosis among women attending a population-based mammography screening program
Abstract
Increased incidence of ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) after introduction of organized screening has prompted debate about overdiagnosis. The aim was to examine the excess in incidence of DCIS and IBC during the screening period and the deficit after women left the program, and thereby to estimate the proportion of overdiagnosis. Women invited to the Norwegian Breast Cancer Screening Program were analyzed for DCIS or IBC during the period 1995-2009. Incidence rate ratios (IRRs) were calculated for attended vs. never attended women. The IRRs were adjusted by Mantel-Haenszel (MH) method and applied to a set of reference rates and a reference population to estimate the proportion of overdiagnosis during the women's lifespan after the age of 50 years. A total of 702,131 women were invited to the program. An excess of DCIS and IBC was observed among women who attended screening during the screening period; prevalently invited women aged 50-51 years had a MH IRR of 1.86 (95% CI 1.65-2.09) and subsequently invited women aged 52-69 years had a MH IRR of 1.56 (95% CI 1.45-1.68). In women aged 70-79 years, a deficit of 30% (MH IRR 0.70, 95% CI 0.62-0.80) was observed 1-10 years after they left the screening program. The estimated proportion of overdiagnosis varied from 10 to 20% depending on outcome and whether the women were invited or actually screened. The results highlight the need for individual data with longitudinal screening history and long-term follow-up as a basis for estimating overdiagnosis.
Copyright © 2013 UICC.
Figures


Comment in
-
Failure to account for selection-bias.Int J Cancer. 2013 Dec 1;133(11):2751-3. doi: 10.1002/ijc.28244. Epub 2013 Jun 17. Int J Cancer. 2013. PMID: 23649899 No abstract available.
-
Response to comments by Kalager et al. and Zahl et al.Int J Cancer. 2013 Dec 1;133(11):2756-7. doi: 10.1002/ijc.28247. Epub 2013 May 29. Int J Cancer. 2013. PMID: 23650012 No abstract available.
-
Overdiagnosis of breast cancer in Norway: what have the authors adjusted for?Int J Cancer. 2013 Dec 1;133(11):2754-5. doi: 10.1002/ijc.28248. Epub 2013 May 29. Int J Cancer. 2013. PMID: 23650050 No abstract available.
Similar articles
-
Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.Ann Intern Med. 2017 Mar 7;166(5):313-323. doi: 10.7326/M16-0270. Epub 2017 Jan 10. Ann Intern Med. 2017. PMID: 28114661
-
The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?Breast Cancer Res Treat. 2019 Apr;174(2):525-535. doi: 10.1007/s10549-018-05095-7. Epub 2018 Dec 18. Breast Cancer Res Treat. 2019. PMID: 30564969
-
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.Breast Cancer Res Treat. 2012 Aug;135(1):291-9. doi: 10.1007/s10549-012-2162-x. Epub 2012 Jul 26. Breast Cancer Res Treat. 2012. PMID: 22833199 Free PMC article.
-
Interpreting overdiagnosis estimates in population-based mammography screening.Epidemiol Rev. 2011;33(1):111-21. doi: 10.1093/epirev/mxr009. Epub 2011 Jun 27. Epidemiol Rev. 2011. PMID: 21709144 Free PMC article. Review.
-
The benefits and harms of breast cancer screening: an independent review.Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30. Lancet. 2012. PMID: 23117178 Review.
Cited by
-
Overdiagnosis: epidemiologic concepts and estimation.Epidemiol Health. 2015 Feb 10;37:e2015004. doi: 10.4178/epih/e2015004. eCollection 2015. Epidemiol Health. 2015. PMID: 25824531 Free PMC article.
-
Overdiagnosis Due to Screening Mammography for Breast Cancer among Women Aged 40 Years and Over: A Systematic Review and Meta-Analysis.J Pers Med. 2023 Mar 14;13(3):523. doi: 10.3390/jpm13030523. J Pers Med. 2023. PMID: 36983705 Free PMC article. Review.
-
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.Br J Cancer. 2013 Oct 1;109(7):2014-9. doi: 10.1038/bjc.2013.427. Epub 2013 Aug 20. Br J Cancer. 2013. PMID: 23963144 Free PMC article.
-
Effect of organised mammography screening on stage-specific incidence in Norway: population study.Br J Cancer. 2016 Mar 1;114(5):590-6. doi: 10.1038/bjc.2016.8. Epub 2016 Feb 2. Br J Cancer. 2016. PMID: 26835975 Free PMC article.
-
Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.CMAJ. 2013 Jul 9;185(10):E492-8. doi: 10.1503/cmaj.121791. Epub 2013 Jun 10. CMAJ. 2013. PMID: 23754101 Free PMC article.
References
-
- Glass AG, Lacey JV, Jr, Carreon JD, et al. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007;99:1152–61. - PubMed
-
- Sorum R, Hofvind S, Skaane P, et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast. 2010;19:499–505. - PubMed
-
- Vainio H, Bianchini F, editors. IARC handbooks of cancer prevention. Breast cancer screening. Vol. 7. Lyon: IARC Press; 2002. p. 229.
-
- Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156:491–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical